Zobrazeno 1 - 10
of 265
pro vyhledávání: '"R. Cellerino"'
Publikováno v:
Advances in Oncology ISBN: 9781315076409
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f08ee60ed191531cba240e494f2bb91f
https://doi.org/10.4324/9781315076409-28
https://doi.org/10.4324/9781315076409-28
Autor:
G. Perona, C. Tregnaghi, Gian Cesare Guidi, Giuliano Moschini, R Cellerino, Bianca Maria Stievano
Publikováno v:
Scandinavian Journal of Haematology. 19:116-120
Erythrocytic glutathione-peroxidase (GSH-Px) activity and plasma selenium concentrations were measured in 14 patients: 7 with iron deficiency and 7 with raised serum iron levels. The decreased enzymatic activity in iron deficiency was confirmed. Plas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97e6117777786c9bfe845b3a10c08405
https://doi.org/10.1111/j.1600-0609.1977.tb02728.x
https://doi.org/10.1111/j.1600-0609.1977.tb02728.x
Autor:
F. Bianchi, S. Rosati, L. Belvederesi, C. Loretelli, R. Catalani, A. Mandolesi, R. Bracci, I. Bearzi, E. Porfiri, R. Cellerino
Publikováno v:
International Journal of Gynecologic Cancer. 16:1419-1423
Hereditary nonpolyposis colorectal cancer (HNPCC) is an inherited syndrome of cancer susceptibility caused by germ line mutations of genes participating in mismatch repair (MMR). Carriers of MMR gene mutations have an increased risk of colorectal can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::332c7f6d3085da0c0f13c564466f8660
https://doi.org/10.1136/ijgc-00009577-200605000-00072
https://doi.org/10.1136/ijgc-00009577-200605000-00072
Autor:
Carlo Maurizio Camaggi, Andrea Martoni, Elena Strocchi, S. Miseria, G. Robustelli Della Cuna, M. Balli, Ettore Bichisao, G. Bonciarelli, G. Ambroso, P. Malacarne, M. Indelli, Franco Pannuti, R. Cellerino
Publikováno v:
Cancer Chemotherapy and Pharmacology. 27:451-455
Drug plasma levels, metabolism data and clinical results were evaluated after the daily administration of either 500 or 1,000 mg aminoglutethimide (AG, Orimeten, Ciba-Geigy) plus hydrocortisone acetate (20 mg b. i. d.). A total of 34 patients with ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64226c65868d959be0237141dd13b9d7
https://doi.org/10.1007/bf00685159
https://doi.org/10.1007/bf00685159
Publikováno v:
Acta Oncologica. 29:417-420
Seventy-four patients with small cell lung cancer (SCLC) entered a program consisting of induction with three courses of CAV (cyclophosphamide, doxorubicin and vincristine) in limited disease or two courses of CAV plus two courses of DDP-VP16 (cispla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::753dbefb1208438b7320cc996006149d
https://doi.org/10.3109/02841869009090023
https://doi.org/10.3109/02841869009090023
Autor:
F, Bianchi, S, Rosati, L, Belvederesi, C, Loretelli, B, Ferretti, I, Bearzi, A, Piga, R, Cellerino, E, Porfiri
Publikováno v:
Clinical genetics. 66(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2f6674f29e875b17b6d9ff09ceed8ffa
https://pubmed.ncbi.nlm.nih.gov/15479195
https://pubmed.ncbi.nlm.nih.gov/15479195
Autor:
R, Berardi, E, Porfiri, M, Scartozzi, P, Lippe, R R, Silva, D, Nacciarriti, E T, Menichetti, D, Tummarello, F, Carle, A, Piga, R, Cellerino
Publikováno v:
Oncology. 65(3)
The incidence of non-small cell lung cancer (NSCLC) is increasing among the elderly. We studied the toxicity and efficacy of a weekly schedule of gemcitabine and cisplatin in elderly patients with advanced NSCLC.Patients aged 70 years or above with a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fec4f3b336d9c47538c7201daf2216a5
https://pubmed.ncbi.nlm.nih.gov/14657592
https://pubmed.ncbi.nlm.nih.gov/14657592
Publikováno v:
Journal of experimentalclinical cancer research : CR. 22(2)
Mucocele-like (ML) lesions of the breast are rare tumours and were reported as benign lesions that histologically resembled colloid carcinoma of the breast when first described about sixteen years ago. Only subsequent reports identified ML lesions as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b444f626dc1407934bf532abe6b55d83
https://pubmed.ncbi.nlm.nih.gov/12866585
https://pubmed.ncbi.nlm.nih.gov/12866585
Autor:
A, Daponte, P A, Ascierto, A, Gravina, M T, Melucci, G, Palmieri, P, Comella, R, Cellerino, M, DeLena, G, Marini, G, Comella
Publikováno v:
Cancer. 89(12)
In a previous study, the authors tested the combination of fotemustine (FM) 100 mg/m(2) intravenously (i.v.) on Day 1, dacarbazine (DTIC) 250 mg/m(2) i.v. on Days 2-5, and interferon alpha (IFNalpha) 3 MIU intramuscularly three times per week in 43 p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cb232d22859907a74cbe53797cd68bf6
https://pubmed.ncbi.nlm.nih.gov/11135225
https://pubmed.ncbi.nlm.nih.gov/11135225
Autor:
A, Piga, R, Bracci, B, Ferretti, P, Sandri, R, Nortilli, L, Acito, A, Pancotti, L, Di Furia, F, Carle, R, Cellerino
Publikováno v:
Journal of experimentalclinical cancer research : CR. 17(2)
Bisphosphonates are used in oncology as a means of decreasing complications due to bone metastases, in association with anticancer treatment, especially in patients with breast cancer, prostate cancer and myeloma. Little is known about the effects of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::265db64727c1c31bd118df67bad56d2a
https://pubmed.ncbi.nlm.nih.gov/9700583
https://pubmed.ncbi.nlm.nih.gov/9700583